New diagnostic tools and treatments for endometriosis
Novel Diagnostic Tools for Endometriosis and Their Exploitation for Prognosis and Prevention of Complications
Turku University Hospital · NCT01301885
This study is trying out new ways to diagnose and treat endometriosis in women to see how they can better manage the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 230 (estimated) |
| Ages | 19 Years to 48 Years |
| Sex | Female |
| Sponsor | Turku University Hospital (other gov) |
| Locations | 4 sites (Helsinki and 3 other locations) |
| Trial ID | NCT01301885 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on endometriosis, a chronic condition affecting many women, characterized by the presence of endometrial tissue outside the uterus. It aims to explore novel diagnostic tools and treatment options, including surgical interventions like laparoscopy and laparotomy. The study will involve women with surgically and pathologically verified endometriosis as well as a control group without the condition. The goal is to better understand the disease and improve management strategies for those affected.
Who should consider this trial
Good fit: Ideal candidates include women with surgically confirmed endometriosis and those without the condition for comparison.
Not a fit: Patients with significant other diseases, malignancy suspicion, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment options for women suffering from endometriosis.
How similar studies have performed: Other studies have explored treatments for endometriosis, but the specific diagnostic tools and approaches in this study may offer novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * study group: surgically and pathologically verified endometriosis * control group: existence of endometriosis ruled out in laparoscopy Exclusion Criteria: * no other significant disease or medication for other diseases * suspicion of malignancy * pregnancy * acute infection * insufficient understanding of Finnish language * previous hysterectomy and/or bilateral salpingo-oophorectomy
Where this trial is running
Helsinki and 3 other locations
- Dept of Obstetrics and Gynecology, Helsinki University Hospital — Helsinki, Finland (COMPLETED)
- Dept of Obstetrics and Gynecology, North Carelia Central Hospital — Joensuu, Finland (COMPLETED)
- Dept of Obstetrics and Gynecology, Päijät-Häme Central Hospital — Lahti, Finland (COMPLETED)
- Dept of Obstetrics and Gynecology, Turku University Central Hospital — Turku, Finland (RECRUITING)
Study contacts
- Principal investigator: Antti Perheentupa, MD, PhD — Department of Obstetrics and Gynecology, Turku University Central Hospital
- Study coordinator: Antti H Perheentupa, MD PhD
- Email: antti.perheentupa@utu.fi
- Phone: +358-2-3130000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Endometriosis, endometriosis, dysmenorrhea, infertility, biomarker, drug target, recurrence, complications